BTHE Boston Therapeutics Inc Stock DD Sunday, March 30, 2014

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
BTHE Boston Therapeutics Inc $BTHE Company Overview 

Stock Message Board http://investorshangout.com/search?q=BTHE&...mp;yt1=Go!

Last Updated: Sunday, March 30, 2014 11:12:03 PM

Boston Therapeutics Inc BTHE Current Price and Quotes
Last Price 0.72
Previous Close 0.72 Open N/A
Daily Range N/A - N/A 52wk Range 1.67 - 0.15
Volume 0 Dividend N/A
Average Vol (3m) 24,768 Yield N/A
Boston Therapeutics Inc BTHE

Company Updated Profile
Company Information

1750 Elm Street
Suite 103
Manchester, NH 03104

Website: http://www.bostonti.com
Phone: 603-935-9799
Email: info@bostonti.com

Boston Therapeutics Inc BTHE
Boston Therapeutics, headquartered in Manchester, NH, (OTCQB: BTHE) is a leader in the field of designing drugs using complex carbohydrates. The Company's product pipeline is focused on developing and commercializing therapeutic molecules for diabetes, including: PAZ320, a non-systemic chewable compound designed to reduce post-meal glucose elevation, and IPOXYN, an injectable anti-necrosis drug specifically designed to treat lower limb ischemia associated with diabetes. More information is avai...



Boston Therapeutics Inc BTHE
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Dec 31, 2013 10-K
CIK 0001473579
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Mar 26, 2012
Incorporated In: DE, USA
Year of Inc. 2009
Employees Not Available
Company Officers/Contacts

David Platt CEO, CFO
Kenneth A. Tassey Jr. President
Anthony Squeglia CFO
Company Directors

Not Available
Service Providers

Auditor/Accountant
Mcgladrey & Pullen LLP (MA)
80 City Square
Boston, MA, 02129
United States

Legal Counsel
Seyfarth Shaw LLP
Two Seaport Lane
Boston, MA, 02210
United States

Investor Relations Firm
DGI Investor Relations, Inc.
75 Maiden Lane
New York, NY, 10038
United States


Boston Therapeutics Inc BTHE
BTHE Security Details

Share Structure

Market Value1 $26,965,567 a/o Mar 28, 2014
Shares Outstanding 37,452,176 a/o Mar 11, 2014
Float 2,309,118 a/o May 18, 2012
Authorized Shares 100,000,000 a/o Sep 30, 2011
Par Value  0.001
Shareholders

Shareholders of Record 1,791 a/o Mar 14, 2014
Short Selling Data

Short Interest 3,350 (2,061.29%)
Mar 14, 2014
Significant Failures to Deliver  No
Transfer Agent(s)

Worldwide Stock Transfer, LLC

Boston Therapeutics Inc BTHE Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 323 42 4 -
Cost of Revenue 278 57 6 -
Gross Profit 45 (15) (2) -
Operating Expenses

Research and Development 542 179 194 11
Sales, General and Admin. 4,083 1,269 615 230
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,580) (1,463) (812) (241)
Income From Continuing Operations

Add'l Income/Expense Items (2) (3) - -
Earnings Before Interest and Tax (4,582) (1,466) (812) (241)
Interest Expense 20 18 16 7
Earnings Before Tax (4,602) (1,484) (827) (248)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,602) (1,484) (827) (248)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,602) (1,484) (827) (248)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (4,602) (1,484) (827) (248)

Boston Therapeutics Inc BTHE Recent News

Mar 27, 2014 Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Boston Therapeutics, Inc.
Mar 17, 2014 Boston Therapeutics Reports Corporate Update and Financial Results for the Fourth Quarter and Year Ended December 31, 2013
Mar 4, 2014 Boston Therapeutics to Initiate a Phase II Clinical Study of BTI-320 in U.S.
Feb 25, 2014 Boston Therapeutics Appoints Larry K. Ellingson, Former Chair of the American Diabetes Association, as Chair of Its Scientific Advisory Board
Feb 11, 2014 Boston Therapeutics Signs Agreement to Market SugarDown(R) in the U.S.


BTHE Boston Therapeutics Inc Research DD Guide

Stock Message Board http://investorshangout.com/search?q=BTHE&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BTHE/quote
Stock Chart http://www.otcmarkets.com/stock/BTHE/chart
Company Info http://www.otcmarkets.com/stock/BTHE/company-info
Recent News http://www.otcmarkets.com/stock/BTHE/news
Financials http://www.otcmarkets.com/stock/BTHE/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BTHE/filings
Short Sales http://www.otcmarkets.com/stock/BTHE/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BTHE/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BTHE/research
Summary http://finance.yahoo.com/q?s=BTHE
Historical Prices http://finance.yahoo.com/q/hp?s=BTHE+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BTHE
Basic Chart http://finance.yahoo.com/q/bc?s=BTHE+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BTHE+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BTHE+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BTHE+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BTHE+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BTHE+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BTHE+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BTHE+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BTHE+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BTHE+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BTHE
Balance Sheet http://finance.yahoo.com/q/bs?s=BTHE
Cash Flow http://finance.yahoo.com/q/cf?s=BTHE+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BTHE
Market Watch http://www.marketwatch.com/investing/stock/BTHE
Bloomberg http://www.bloomberg.com/quote/BTHE:US
Morningstar http://quotes.morningstar.com/stock/s?t=BTHE
Bussinessweek http://investing.businessweek.com/research/st...icker=BTHE
Barchart http://www.barchart.com/quotes/stocks/BTHE
OTC Short Report http://otcshortreport.com/index.php?index=BTHE
Investopedia http://www.investopedia.com/markets/stocks/BTHE/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Trump Announces Coca-Cola Will Switch to Real Cane Sugar

Updated Category News Views 287

Coca-Cola Embraces Change with Real Cane Sugar Recently, former President Donald Trump announced an exciting development for soda enthusiasts. He confirmed that Coca-Cola Co. KO has agreed to switch from high-fructose corn syrup to real cane sugar in its beverages sold in the United States. Trump's Announcement on Social Media In a post on Truth Social, Trump stated, "I...

Continue Reading
Top Two AI-Driven Customer Engagement Platform Stocks for Growth

Updated Category News Views 272

Understanding Customer Engagement Platforms In today's tech-savvy world, the concept of Customer Engagement Platforms (CEPs) is vital for success in business strategies. CEPs leverage artificial intelligence to enable companies to interact with their customers effectively, facilitating strong brand loyalty and long-term patronage. This crucial interaction helps businesses...

Continue Reading
Asia Pacific Airlines Surge in Popularity with HKG-TPE Route

Updated Category News Views 156

Hong Kong to Taipei: The Busiest International Airline Route According to the latest data, the flight route from Hong Kong (HKG) to Taipei (TPE) has emerged as the world's busiest international airline route in 2024. This revelation, sourced from data analysis, showcases a significant increase in flight capacity and demand compared to previous years. Impressive Growth in...

Continue Reading
WeRide Launches First Fully Autonomous Robobus in Shenzhen

Updated Category News Views 173

WeRide Introduces Landmark Fully Autonomous Robobus Line WeRide has teamed up with Shenzhen Bus Group to announce the launch of the city’s first fully driverless Level 4 robobus line. Located in a bustling district, this innovative transport solution is designed to enhance urban mobility and represents a significant step towards smart city initiatives. Details of the...

Continue Reading
Unlocking Profitable Cryptocurrency Mining with Rich Miner

Updated Category News Views 309

A Comprehensive Look at Rich Miner in the Cryptocurrency Landscape As the world of cryptocurrency continues to evolve, investors are increasingly searching for platforms that not only offer profitability but also prioritize security and environmental sustainability. One such leading platform is Rich Miner. Recognized as the "Best Cloud Mining Platform of the Year," Rich...

Continue Reading